- Home
- EWCZ vs CDXS Comparison
EWCZ vs CDXS Comparison
Compare EWCZ & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWCZ
- CDXS
- Stock Information
- Founded
- EWCZ 2004
- CDXS 2002
- Country
- EWCZ United States
- CDXS United States
- Employees
- EWCZ N/A
- CDXS N/A
- Industry
- EWCZ Package Goods/Cosmetics
- CDXS Major Chemicals
- Sector
- EWCZ Consumer Discretionary
- CDXS Industrials
- Exchange
- EWCZ Nasdaq
- CDXS Nasdaq
- Market Cap
- EWCZ 239.2M
- CDXS 254.3M
- IPO Year
- EWCZ 2021
- CDXS 2010
- Fundamental
- Price
- EWCZ $4.15
- CDXS $2.49
- Analyst Decision
- EWCZ Hold
- CDXS Buy
- Analyst Count
- EWCZ 6
- CDXS 2
- Target Price
- EWCZ $5.50
- CDXS $11.00
- AVG Volume (30 Days)
- EWCZ 375.3K
- CDXS 945.1K
- Earning Date
- EWCZ 11-13-2025
- CDXS 10-30-2025
- Dividend Yield
- EWCZ N/A
- CDXS N/A
- EPS Growth
- EWCZ N/A
- CDXS N/A
- EPS
- EWCZ 0.20
- CDXS N/A
- Revenue
- EWCZ $212,509,000.00
- CDXS $57,164,000.00
- Revenue This Year
- EWCZ N/A
- CDXS $12.88
- Revenue Next Year
- EWCZ $2.37
- CDXS $21.64
- P/E Ratio
- EWCZ $20.58
- CDXS N/A
- Revenue Growth
- EWCZ N/A
- CDXS N/A
- 52 Week Low
- EWCZ $2.72
- CDXS $1.90
- 52 Week High
- EWCZ $8.91
- CDXS $6.08
- Technical
- Relative Strength Index (RSI)
- EWCZ 46.34
- CDXS 44.57
- Support Level
- EWCZ $3.83
- CDXS $2.34
- Resistance Level
- EWCZ $3.96
- CDXS $2.54
- Average True Range (ATR)
- EWCZ 0.19
- CDXS 0.12
- MACD
- EWCZ 0.02
- CDXS 0.00
- Stochastic Oscillator
- EWCZ 67.47
- CDXS 42.55
About EWCZ European Wax Center Inc.
European Wax Center Inc is a franchisor and operator of OOH waxing services. Its product sales consist of revenue earned from sales of proprietary wax. Its services include Brazilian Waxing, Brow Waxing, Body Waxing, Facial Waxing, All Waxing Services, Eyebrow Tinting, Laser Hair Removal, Men's Waxing Services and others.
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.